News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,684 Results
Type
Article (42459)
Company Profile (294)
Press Release (674931)
Multimedia
Podcasts (78)
Webinars (12)
Section
Business (210430)
Career Advice (2091)
Deals (36628)
Drug Delivery (107)
Drug Development (83051)
Employer Resources (175)
FDA (16572)
Job Trends (15406)
News (356032)
Policy (33916)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2598)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (51424)
ALS (91)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (130)
Approvals (16573)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (16)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (111)
Biotechnology (188)
Bladder cancer (66)
Brain cancer (28)
Breast cancer (274)
Cancer (2203)
Cardiovascular disease (179)
Career advice (1751)
Career pathing (31)
CAR-T (147)
Cell therapy (413)
Cervical cancer (19)
Clinical research (67464)
Collaboration (837)
Compensation (525)
Complete response letters (25)
COVID-19 (2656)
CRISPR (43)
C-suite (239)
Cystic fibrosis (103)
Data (2109)
Decentralized trials (2)
Denatured (28)
Depression (44)
Diabetes (267)
Diagnostics (6441)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (110)
Drug shortages (28)
Duchenne muscular dystrophy (93)
Earnings (88141)
Editorial (37)
Employer branding (21)
Employer resources (149)
Events (114984)
Executive appointments (722)
FDA (17806)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (107)
Generative AI (21)
Gene therapy (304)
GLP-1 (745)
Government (4534)
Grass and pollen (5)
Guidances (52)
Healthcare (18996)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2799)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (94)
Interviews (322)
IPO (16777)
IRA (47)
Job creations (4056)
Job search strategy (1492)
Kidney cancer (10)
Labor market (38)
Layoffs (485)
Leadership (17)
Legal (8379)
Liver cancer (74)
Lung cancer (313)
Lymphoma (149)
Machine learning (6)
Management (59)
Manufacturing (310)
MASH (67)
Medical device (13446)
Medtech (13451)
Mergers & acquisitions (20375)
Metabolic disorders (693)
Multiple sclerosis (77)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (29)
Neuroscience (1929)
NextGen: Class of 2025 (6637)
Non-profit (4525)
Northern California (2609)
Now hiring (39)
Obesity (373)
Opinion (229)
Ovarian cancer (74)
Pain (91)
Pancreatic cancer (82)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (106)
Peanut (49)
People (59230)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20920)
Phase II (29681)
Phase III (22251)
Pipeline (1151)
Policy (148)
Postmarket research (2654)
Preclinical (8876)
Press Release (68)
Prostate cancer (101)
Psychedelics (31)
Radiopharmaceuticals (250)
Rare diseases (391)
Real estate (6257)
Recruiting (67)
Regulatory (23096)
Reports (46)
Research institute (2368)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (131)
Series B (84)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2243)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3725)
State (2)
Stomach cancer (14)
Supply chain (68)
Tariffs (36)
The Weekly (48)
United States (22702)
Vaccines (696)
Venture capitalists (41)
Weight loss (250)
Women's health (35)
Worklife (15)
Date
Today (50)
Last 7 days (655)
Last 30 days (2447)
Last 365 days (33251)
2025 (10020)
2024 (35770)
2023 (40631)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32663)
2015 (38617)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (52)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (40692)
Australia (6516)
California (5967)
Canada (1981)
China (518)
Colorado (263)
Connecticut (266)
Delaware (142)
Europe (86819)
Florida (882)
Georgia (202)
Idaho (57)
Illinois (533)
India (26)
Indiana (314)
Iowa (11)
Japan (161)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (879)
Massachusetts (4486)
Michigan (218)
Minnesota (386)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1696)
New Mexico (29)
New York (1698)
North Carolina (971)
North Dakota (7)
Northern California (2609)
Ohio (199)
Oklahoma (14)
Oregon (39)
Pennsylvania (1345)
Puerto Rico (11)
Rhode Island (32)
South America (1162)
South Carolina (22)
South Dakota (1)
Southern California (2243)
Tennessee (101)
Texas (889)
Utah (179)
Virginia (149)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (54)
717,684 Results for "oramed pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - June 26, 2024
Oramed Pharmaceuticals Inc. announced today that its Board of Directors has authorized a common stock repurchase plan allowing for the buy-back of up to $20,000,000 in maximum value of its common stock through open market purchases, privately-negotiated transactions, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, over the next 12 months.
June 26, 2024
·
4 min read
Press Releases
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
January 21, 2025
·
6 min read
Pharm Country
Oramed Letter to Shareholders - June 26, 2024
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron.
June 26, 2024
·
7 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Pharm Country
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
Oramed Pharmaceuticals Inc. announced that on September 21, 2023, Oramed and Scilex Holding Company entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note to Oramed.
September 21, 2023
·
6 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Pharm Country
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
Oramed Pharmaceuticals Inc. announced that it has signed a non-binding term sheet with Hefei Tianhui Biotech Co., Ltd. to establish a joint venture based on Oramed’s oral drug delivery technology.
August 2, 2023
·
5 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025
April 21, 2025
·
4 min read
Pharm Country
Oramed Pharmaceuticals Issues Shareholder Update - February 09, 2023
Oramed Pharmaceuticals Inc., announced that it continues to conduct a comprehensive analysis of the data from its discontinued Phase 3 oral insulin trials.
February 9, 2023
·
4 min read
1 of 71,769
Next
